Friday, August 08, 2008 2:08:50 AM
http://finance.yahoo.com/echarts?s=MNTA#chart2:symbol=mnta;range=ytd;compare=rprx;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined
No commentary necessary... charts don't lie.
"Thomas, not sure if you are hiding on your MNTA post but fyi MNTA now has about $2.50 a share in net cash once you include the Oct-Feb burn rate, paying down debt and excess of payables over receivables and they are burning more than %0.50 per quarter. So cash position is not a positive investment thesis. What am i missing?" {lol...}
"Thomas, what is the basis for your positive inclination on MNTA that it was a "better opportunity"? They probably have 30 MM less cash now than as of 9/30 balance sheet you may be citing so they could be well below $4 per share in cash with no products or no hope. Why will this not go to zero in a year or two?" {because it is going to $20?}
A veritable "who's who" of Institutional Holders:
PRICE (T.ROWE) ASSOCIATES INC 3,199,199 8.70 $34,967,245 31-Mar-08
Visium Asset Management 3,152,336 8.57 $34,455,032 31-Mar-08
FEDERATED INVESTORS, INC. 2,032,500 5.52 $22,215,225 31-Mar-08
Ridgeback Capital Investments Ltd 1,864,826 5.07 $20,382,548 31-Mar-08
MORGAN STANLEY 1,391,711 3.78 $15,211,401 31-Mar-08
PALO ALTO INVESTORS, LLC 1,327,658 3.61 $14,511,301 31-Mar-08
Barclays Global Investors UK Holdings Ltd 1,192,843 3.24 $13,037,773 31-Mar-08
VANGUARD GROUP, INC. (THE) 921,451 2.50 $10,071,459 31-Mar-08
HAMBRECHT & QUIST CAPITAL MANAGEMENT, INC. 829,200 2.25 $9,063,156 31-Mar-08
OHIO-STATE TEACHERS RETIREMENT SYSTEM 562,433 1.53 $6,147,392 31-Mar-08
TOP MUTUAL FUND HOLDERS
Holder Shares % Out Value* Reported
FEDERATED KAUFMANN FUND 1,754,500 4.77 $12,825,395 31-Jan-08
PRICE (T.ROWE) NEW HORIZONS FUND 1,600,000 4.35 $17,488,000 31-Mar-08
H&Q HEALTHCARE INVESTORS 489,250 1.33 $5,347,502 31-Mar-08
FIDELITY GROWTH COMPANY FUND 406,000 1.10 $5,204,920 31-May-08
PRICE (T.ROWE) SMALL-CAP VALUE FUND 360,000 .98 $3,934,800 31-Mar-08
H&Q LIFE SCIENCES INVESTORS 339,950 .92 $3,715,653 31-Mar-08
ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND 282,603 .77 $3,476,016 30-Jun-08
VANGUARD TOTAL STOCK MARKET INDEX FUND 267,373 .73 $2,922,386 31-Mar-08
ISHARES RUSSELL 2000 INDEX FD 217,607 .59 $2,378,444 31-Mar-08
VANGUARD SMALL-CAP INDEX FUND 210,136 .57 $2,296,786 31-Mar-08
"The Holocaust was an obscene period in our nation's history. I mean in this century's history. But we all lived in this century. I didn't live in this century."
- Dan Quayle
"Illegitimacy is something we should talk about in terms of not having it."
- Dan Quayle
Recent RPRX News
- Royalty Pharma Declares Fourth Quarter 2024 Dividend • GlobeNewswire Inc. • 10/11/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 12:39:00 PM
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement • GlobeNewswire Inc. • 09/03/2024 09:14:32 PM
- Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement • GlobeNewswire Inc. • 09/03/2024 09:06:29 PM
- Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:20:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:19:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 01:02:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:20:53 AM
- Royalty Pharma Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:04:01 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/29/2024 08:30:11 PM
- Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital • GlobeNewswire Inc. • 07/24/2024 12:30:00 PM
- Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/19/2024 12:15:00 PM
- Royalty Pharma Declares Third Quarter 2024 Dividend • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:03:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:58:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:06:32 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/04/2024 09:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:57:02 PM
- Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 08:15:00 PM
- Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes • GlobeNewswire Inc. • 06/03/2024 09:15:27 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 06/03/2024 08:59:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 01:13:40 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM